EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology…
Ghent, Belgium, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Milestone in bringing breakthrough treatment option to US patients with recurrent and…
November 21, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Nov. 21, 2025 (GLOBE NEWSWIRE) --…
November 21, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”,…
November 21, 2025 16:30 ET | Source: Conavi Medical Corp. PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ NOT FOR RELEASE OR DISTRIBUTION…
Company earns five Golds for its NCQA-accredited health navigation platform, Diabetes Prevention Program, and patient education and engagement solutions November…
Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase…
November 21, 2025 09:00 ET | Source: InspireMD Inc. MIAMI, Nov. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR)…
Company Announcement COPENHAGEN, Denmark; November 20, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided…
November 20, 2025 13:37 ET | Source: DLH Holdings Corp. ATLANTA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp.…